The long-term effect of AHSCT on MRI measures of MS evolution: A five-year follow-up study

Multiple Sclerosis

Volumn 13, Issue 8, 2007, Pages 1068-1070

  Roccatogliata, L ^a   Rocca, M A ^b   Valsasina, P ^b   Bonzano, L ^a   Sormani, M P ^a,b   Saccardi, R ^c   Mancardi, G L ^a   Filippi, Massimo ^b   Marrosu, M G ^d   La Nasa, G ^d   Cocco, E ^d   Cherchi, V ^d   Lugaresi, A ^d   Di Bartolomeo, P ^d   Farina, D ^d   Ialori, C ^d   Tartaro, A ^d   Massacesi, L ^d   Pagliai, F ^d   Bosi, A ^d   Repice, A ^d   Konze, A ^d   Sardanelli, F ^d   Capello, E ^d   Murialdo, A ^d   Gualandi, F ^d   Parodi, R C ^d   Dogliotti, L ^d   Marmont, A ^d   Inglese, M ^d   Comi, G ^d   Donelli, A ^d   Merelli, E ^d   Casoni, F ^d   Cavalleri, F ^d   Bertolotto, A ^d   Guerrasio, A ^d   Capobianco, M ^d   Duca, S ^d   Meucci, G ^d   Papineschi, F ^d   Mosti, S ^d   Abruzzese, A ^d   more..

^a UNIVERSITY OF GENOA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d NONE

Author keywords

Atrophy; Autologous hematopoietic stem cell transplantation; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRAIN ATROPHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; INFLAMMATION; LONG TERM CARE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ATROPHY; AUTOTRANSPLANTATION; BRAIN; CLINICAL TRIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; ONSET AGE; PATHOLOGY; STEM CELL MOBILIZATION;

ADULT; AGE OF ONSET; ATROPHY; BRAIN; CYCLOPHOSPHAMIDE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE SCLEROSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 34848868292     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507076982     Document Type: Article

References (11)

1. Blanco Y, Saiz A, Carreras E, Graus F. Autologous haematopoietic stem-cell transplantation for multiple sclerosis. Lancet Neurol 2005; 4: 54-63.
2. Chen JT, Collins DL, Atkins HL, Freedman MS, Galal A, Arnold DL. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis. Neurology 2006; 66: 1935-37.
3. Inglese M, Mancardi GL, Pagani E, Rocca MA, Murialdo A et al. Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation. J Neurol Neurosurg Psychiatry 2004; 75: 643-44.
4. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002; 125: 1676-95.
5. Fisher E, Rudick RA, Simon JH, Cutter G, Baier M, Lee JC et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002; 59: 1412-20.
6. Mancardi GL, Saccardi R, Filippi M, Gualandi F, Murialdo A. Inglese M et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 2001; 57: 62-68.
7. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-89.
8. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
9. Kutzelnigg A, Lucchinetti CF, Stadelman C, Bruck W, Rauschka H, Bergmann M et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-12.
10. Jager HR, Williams EJ, Savage DG, Rule SA, Hajnal JV, Sikora K et al. Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia. AJNR Am J Neuroradiol 1996; 17: 1275-82.
11. Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 2006; 253: 98-108.